Liabilities and Equity in USD of FibroBiologics, Inc. from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
FibroBiologics, Inc. quarterly Liabilities and Equity history and change rate from Q4 2022 to Q3 2025.
  • FibroBiologics, Inc. Liabilities and Equity for the quarter ending 30 Sep 2025 was $8,744,000, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

FibroBiologics, Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,744,000 -$1,725,000 -16% 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q2 2025 $13,907,000 +$4,995,000 +56% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $11,426,000 +$27,000 +0.24% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $16,445,000 +$4,624,000 +39% 31 Dec 2024 10-Q 31 Oct 2025 2025 Q3
Q3 2024 $10,469,000 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $8,912,000 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $11,399,000 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $11,821,000 +$6,997,000 +145% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $4,824,000 31 Dec 2022 10-K 29 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.